MedTrace Logo

Testing Gender-based Violence Response in Family Planning and Antenatal Care Services in Nigeria

NCT05331508 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1756

Last updated 2023-08-07

No results posted yet for this study

Summary

To pilot and evaluate the integration of first-line response to gender- based violence (GBV), particularly intimate partner violence (IPV), sexual violence and reproductive coercion, within family planning (FP) and antenatal care (ANC) services at public health facilities in Ebonyi and Sokoto states in Nigeria.

GBV first-line response in the health setting includes screening , empowerment counseling, safety planning, and support to connect to additional services needed.

Conditions

  • Gender-based Violence
  • Reproductive Coercion
  • Intimate Partner Violence

Interventions

BEHAVIORAL

gender-based violence screening, first-line support (LIVES) and reproductive coercion empowerment counseling (ARCHES)

Providers will (1) introduce routine client screening for GBV, including intimate partner violence, sexual violence, and reproductive coercion using a standardized screening form, in FP and ANC services,(2) for individuals disclosing GBV, provide first-line response-empathetic counseling, including listening, inquiring about experiences sensitively, and validating experiences, helping clients develop safety plans, and providing support; (3) regardless of disclosure of GBV, provide counseling and information, education and communication (IEC) materials on IPV, including reproductive coercion, and FP options, to both FP and ANC clients.

Sponsors & Collaborators

  • Jhpiego

    lead OTHER

Principal Investigators

  • Myra Betron · Jhpiego

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-06
Primary Completion
2023-04-30
Completion
2023-06-30

Countries

  • Nigeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05331508 on ClinicalTrials.gov